Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9436069 | 1.00 | TAAR1 (0.57) | TAAR1TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL4847978 | 1.00 | TAAR1 (0.57) | TAAR1TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL9435765 | 0.98 | TAAR1 (0.59) | TAAR1TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL1769146 | 0.91 | — | — | |
| SCHEMBL8571535 | 0.89 | TAAR1 (0.70) | TAAR1TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL6734915 | 0.89 | TAAR1 (0.70) | TAAR1TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL7116263 | 0.89 | TAAR1 (0.70) | TAAR1TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL20146704 | 0.87 | TAAR1 (0.73) | TAAR1TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL1309426 | 0.82 | — | — | |
| SCHEMBL20135772 | 0.82 | TAAR1 (0.73) | TAAR1TSHRADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7700643-B2 | Polymerisable thieno[3,2-b]thiophenes | MERCK PATENT GMBH (DE) | 2010-04-20 | — | — | US | disclosed |
| US-7700643-B2 | Polymerisable thieno[3,2-b]thiophenes | MERCK PATENT GMBH (DE) | 2010-04-20 | — | — | US | disclosed |
| US-7700643-B2 | Polymerisable thieno[3,2-b]thiophenes | MERCK PATENT GMBH (DE) | 2010-04-20 | — | — | US | disclosed |
| CN-101693722-A | Polymerisable thieno not 3,2-b thiophenes | MERCK PATENT GMBH | 2010-04-14 | — | — | CN | disclosed |
| US-7674397-B2 | Reactive mesogenic charge transport compounds | Merck Patent Gesellschaff mit beschrankter Haftung (DE) | 2010-03-09 | — | — | US | disclosed |
| US-7674397-B2 | Reactive mesogenic charge transport compounds | Merck Patent Gesellschaff mit beschrankter Haftung (DE) | 2010-03-09 | — | — | US | disclosed |
| US-7674397-B2 | Reactive mesogenic charge transport compounds | Merck Patent Gesellschaff mit beschrankter Haftung (DE) | 2010-03-09 | — | — | US | disclosed |
| US-20070246704-A1 | Polymerisable ThienO[3,2-B]Thiophenes | MERCK PATENT GMBH (DE) | 2007-10-25 | — | — | US | disclosed |
| US-20070246704-A1 | Polymerisable ThienO[3,2-B]Thiophenes | MERCK PATENT GMBH (DE) | 2007-10-25 | — | — | US | disclosed |
| US-20070246704-A1 | Polymerisable ThienO[3,2-B]Thiophenes | MERCK PATENT GMBH (DE) | 2007-10-25 | — | — | US | disclosed |
| CN-1964980-A | Polymerizable thieno [3, 2-b ] thiophenes | MERCK PATENT GMBH (DE) | 2007-05-16 | — | — | CN | disclosed |
| EP-1753768-A1 | POLYMERISABLE THIENO¬3,2-b|THIOPHENES | Merck Patent GmbH (DE) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005121150-A1 | POLYMERISABLE THIENO[3,2-b]THIOPHENES | MERCK PATENT GMBH (DE) | 2005-12-22 | — | — | WO | disclosed |
| US-20050184274-A1 | Reactive mesogenic charge transport compounds | MERCK PATENT GMBH (DE) | 2005-08-25 | — | — | US | disclosed |
| US-5306601-A | Laminating a semiconductor a polythiophenes layer, inorganic layer and photoresists layer, heating and hardening each layer | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1994-04-26 | — | — | US | disclosed |
| EP-0348961-B1 | Fine pattern forming material and pattern forming method | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 1994-01-26 | — | — | EP | disclosed |
| EP-0530849-A2 | Fine pattern forming material and pattern forming method | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1993-03-10 | — | — | EP | disclosed |
| EP-0348961-A2 | Fine pattern forming material and pattern forming method | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1990-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070246704-A1 | Polymerisable ThienO[3,2-B]Thiophenes | TPR, OR10J3, FTO | TAAR1 1027/4885TSHR 672/4885ADRA2A 2566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.